VEGFA and hereditary hemorrhagic telangiectasia: Although several angiogenic proteins are dysregulated in HHT [2], elevated levels of vascular endothelial growth factor (VEGF) [3, 4] is of clinical interest due to the availability of targeted anti-VEGF agents.